US 9925209
Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
granted A61KA61K2039/505A61K31/7088
Quick answer
US patent 9925209 (Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same) held by The Board of Regents of the University of Oklahoma expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K31/7088, A61K38/193, A61K38/21